Literature DB >> 596969

A pulsatile assist device (PAD) for use during cardiopulmonary bypass.

D Bregman, M Bailin, F O Bowman, E N Parodi, S M Haubert, R N Edie, H M Spotnitz, K Reemtsma, J R Malm.   

Abstract

A pulsatile assist device (PAD) has been developed to convert roller pump flow to pulsatile flow in a simple fashion. The device can also be used as an arterial counterpulsator before and after cardiopulmonary bypass. The PAD has been used in 125 adult patients undergoing open-heart operations for coronary artery or valvular heart disease or the combination. Ninety-two patients were in New York Heart Association Functional Class III or IV or had ejection fractions of less than 0.3. The PAD functioned as a hemodynamically effective arterial counterpulsator before and after perfusion. All patients were successfully weaned from bypass with the PAD. There has been 1 intraoperative death and 2 late deaths. Only 1 patient had a perioperative myocardial infarction, and this person was successfully treated with intraaortic balloon pumping. We believe the PAD is a simple and reliable device for intraoperative counterpulsation and for the creation of pulsatile cardiopulmonary bypass. More important, use of the PAD may decrease both the incidence of perioperative myocardial infarction and the need for postoperative intraaortic balloon pumping.

Entities:  

Mesh:

Year:  1977        PMID: 596969     DOI: 10.1016/s0003-4975(10)63461-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Experience with intra-aortic balloon pumping and the first clinical application of an ellipsoid left ventricular assist device: invited commentary.

Authors:  D Bregman
Journal:  World J Surg       Date:  1978-11       Impact factor: 3.352

2.  Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients.

Authors:  K M Taylor; W H Bain; K G Davidson; M A Turner
Journal:  Thorax       Date:  1982-05       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.